CYP3A-inducing antiepileptics decrease sorafenib exposures: Results of a phase II study in adults with recurrent glioblastoma. Background: The apparent diffusion coefficient (ADC) obtained from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback